FORM OF LOCK-UP AGREEMENT
February 1, 2002
Bioenvision, Inc.
Xxxxx 0000
Xxx Xxxxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
and
Each of the Former Stockholders of Pathagon Inc.
whose names and addresses are set forth on Schedule A
hereto
c/o Pathagon Inc.
1285 Avenue of the Xxxxxxxx, 00xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Gentlemen:
Reference is made to that certain Amended and
Restated Agreement and Plan of Merger, dated as of the date
hereof (the "Merger Agreement"), among Bioenvision, Inc.
("Bioenvision"), Bioenvision Acquisition Corp. and Pathagon
Inc. ("Pathagon") and that certain Registration Rights
Agreement, dated as of the date hereof, by and among
Bioenvision and each of the former stockholders of Pathagon
listed on Schedule A hereto (the "Registration Rights
Agreement"). Capitalized terms used not otherwise defined
herein shall have the respective meanings ascribed to such
terms in the Registration Rights Agreement.
The undersigned hereby agrees that from the date
hereof until the date and time upon which a registration
statement filed by Bioenvision with the Commission which
registers the resale of all of the Registrable Securities
has become effective under the Securities Act, the
undersigned will not offer, sell or otherwise dispose of, or
contract to dispose of (or announce any offer, sale, grant
of any option to purchase or other disposition of), pledge
or hypothecate, directly or indirectly, any shares of common
stock, par value $.001 per share, of Bioenvision (the
"Common Stock"), any options or warrants to purchase any
shares of Common Stock, or any securities convertible into
or exchangeable for shares of Common Stock, directly or
indirectly, without the prior written consent of a majority
in interest of the former stockholders of Pathagon listed on
Schedule A hereto.
Very truly yours,
______________________
[Name of Director, Officer or 5% Stockholder]
Schedule A
Al-Mandani Investment Co. Ltd.
Xxxxxxxx. Xxxxx Xx-Xxxxxx
XX Xxx 00000
Xx-Xxxxx Xxxx, Xxxx 0
Xxxxxx - 00000, Xxxxx Xxxxxx
Benefit Capital Management
Xxxxx Xxxxxx
Dow Chemical Company
Dorinco 100
Xxxxxxx, XX 00000
000-000-0000
xxxxxxxxx@xxx.xxx
Community Investment Partners III, LP, LLLP
Xxxxxx X. Xxxxxxxxx
00000 Xxxxxxxxxx Xxxx
Xx. Xxxxx, XX 00000
Xxxxx Xxxxxxxxx
X/x Xxxxxx Xxxxxxxxx
00 Xxxxx Xxxxxxx
Xxxxxxxxxx, XX 00000-0000
000-000-0000
Xxxxxx Xxxxx
0 Xxxxxxxx Xxxx
Xxxxxx Xxxxxx, XX 00000
000-000-0000
XxxxXxxxx@xxx.xxx
Xxxxxxxx X. Xxxxxxxxx
Xxxxxxxxx 00
X-0000 Xxxxxxxx, Xxxxxx
Gutrafin, Ltd.
Xxxxxxx X. Xxxx
00 Xxxxxxx Xxxxxxxx
Xxxxxx, XX0 0XX
Xxxxxx Xxxxxxx
Fax : 00-000-000-0000
Hoegh Invest A/S
Xxxx Xxxxxx Xxxxx
Chairman
Xxxxxxxxx 00
XX Xxx 0000 Xxxxx
0000 Xxxx - Xxxxxx
Oakwood Investors I, LLC
Xxxxx X. Xxxxx, Xx.
000 Xxxxxx Xxxxx
Xx. Xxxxx, XX 00000
Fax : 000-000-0000
Xxxxxx X. Xxxxxxx
X/x Xxxxxx Xxxxxxxxx
00 Xxxxx Xxxxxxx
Xxxxxxxxxx, XX 00000-0000
000-000-0000
SCO Capital Partners
Xxxxxx X. Xxxxxxxxx
1285 Avenue of the Xxxxxxxx
00xx Xxxxx
Xxx Xxxx, XX 00000
SCO Financial Group
Xxxxxx X. Xxxxxxxxx
1285 Avenue of the Xxxxxxxx
00xx Xxxxx
Xxx Xxxx, XX 00000
Xxxxxx X. Xxxxx
00 Xxxx Xxxx Xxxx
Xxxxxxxxxx, XX 00000
Xxxxxxx X. Xxxxx
00 Xxxxxxxx Xxxx
Xxxxxx, XX 00000
